Ernst Russ AG (FRA:HXCK)
Germany · Delayed Price · Currency is EUR 6.74
-0.08 (-1.17%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | - | 42.47 | 55.08 | 47.27 | 15.78 | 4.13 | Upgrade |
Depreciation & Amortization | - | 26.12 | 31.98 | 32.19 | 8.35 | 8.18 | Upgrade |
Loss (Gain) From Sale of Assets | - | -2 | -15.75 | -21.09 | -0.05 | 0.86 | Upgrade |
Loss (Gain) From Sale of Investments | - | 0.21 | 3.33 | 1.29 | 0.34 | 0.07 | Upgrade |
Other Operating Activities | - | 23.63 | 24.08 | 34.16 | 12.07 | -1.51 | Upgrade |
Change in Inventory | - | 1.33 | 2.35 | -4.31 | -0.58 | -2.77 | Upgrade |
Change in Accounts Payable | - | -1.69 | -5.51 | 5.75 | 2.87 | - | Upgrade |
Change in Other Net Operating Assets | - | 8.4 | -5.38 | 3.5 | 0.95 | -0.93 | Upgrade |
Operating Cash Flow | - | 98.47 | 90.18 | 98.75 | 39.72 | 8.03 | Upgrade |
Operating Cash Flow Growth | - | 9.20% | -8.68% | 148.65% | 394.59% | -34.44% | Upgrade |
Capital Expenditures | - | -3.89 | -98.08 | -33.81 | -3.12 | -21.15 | Upgrade |
Sale of Property, Plant & Equipment | - | 5.03 | 26.75 | 45.8 | 0 | 0.03 | Upgrade |
Cash Acquisitions | - | - | -6.56 | -2.37 | 6.46 | - | Upgrade |
Divestitures | - | 0.75 | 2.68 | 1.23 | 1.54 | 0.66 | Upgrade |
Sale (Purchase) of Intangibles | - | -0.01 | -0.03 | -0.19 | -0.33 | 0 | Upgrade |
Investment in Securities | - | 0.38 | 0.11 | -0.59 | -33.29 | -2.96 | Upgrade |
Other Investing Activities | - | 4.25 | 3.31 | 2.52 | 1.2 | 2.57 | Upgrade |
Investing Cash Flow | - | 6.51 | -71.82 | 12.6 | -27.54 | -20.85 | Upgrade |
Long-Term Debt Issued | - | - | 35.7 | 30.84 | 52.82 | 24.35 | Upgrade |
Long-Term Debt Repaid | - | -13.43 | -22.61 | -103.05 | -42.44 | -14.92 | Upgrade |
Net Debt Issued (Repaid) | - | -13.43 | 13.09 | -72.21 | 10.38 | 9.43 | Upgrade |
Issuance of Common Stock | - | 0.07 | 1.87 | 4.19 | 0.91 | 5.09 | Upgrade |
Common Dividends Paid | - | -32.5 | -1.88 | - | - | - | Upgrade |
Other Financing Activities | - | -20.35 | -20.38 | -12.61 | -4.88 | -2.93 | Upgrade |
Financing Cash Flow | - | -66.21 | -7.3 | -80.64 | 6.41 | 11.59 | Upgrade |
Foreign Exchange Rate Adjustments | - | 4.6 | -1.5 | 0.67 | -0.93 | 0.42 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0.49 | - | Upgrade |
Net Cash Flow | - | 43.37 | 9.55 | 31.39 | 17.17 | -0.82 | Upgrade |
Free Cash Flow | - | 94.58 | -7.9 | 64.95 | 36.6 | -13.12 | Upgrade |
Free Cash Flow Growth | - | - | - | 77.48% | - | - | Upgrade |
Free Cash Flow Margin | - | 54.76% | -3.90% | 33.87% | 39.37% | -23.45% | Upgrade |
Free Cash Flow Per Share | - | 2.81 | -0.24 | 2.01 | 1.14 | -0.38 | Upgrade |
Cash Interest Paid | - | 1.62 | 1.6 | 2.95 | 3.31 | 2.93 | Upgrade |
Cash Income Tax Paid | - | 0.26 | 1.98 | 0.9 | 0.63 | -0.2 | Upgrade |
Levered Free Cash Flow | - | 65.24 | -14.96 | 49.91 | 43.58 | -27.65 | Upgrade |
Unlevered Free Cash Flow | - | 66.15 | -14.16 | 51.68 | 45.78 | -25.84 | Upgrade |
Change in Net Working Capital | - | -12.44 | -12.11 | -21.07 | -26.45 | 13.2 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.